Hormone receptor status and pathologic response of HER2-positive breast cancer treated with neoadjuvant chemotherapy and trastuzumab
200850 citationsJournal Articlebronze Open Access
Field-Weighted Citation Impact: 3.71
Hormone receptor status and pathologic response of HER2-positive breast cancer treated with neoadjuvant chemotherapy and trastuzumab | Researchclopedia